Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02345772
Title Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy (Taxotere, Trastuzumab and Pertuzumab) in Patients With HER2-positive and ER-Positive Breast Cancer
Acronym Neohttp
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Western Regional Medical Center
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.